Pharmacological management | |
First line uterotonic: oxytocin in step1 | |
Second line uterotonic: sulprostone (prostaglandin E2 analogue) in step2 | |
No misoprostol (prostaglandin E1 analogue) in any step | |
Non-pharmacological management | |
Manual placental delivery, manual examination of the uterine cavity in step1 | |
No intrauterine tamponade in step 1 | |
No torsion of the cervix in step 1 | |
Uterine massage in steps 1 or 2 | |
Cervical examination with speculum in steps 1 or 2 | |
No surgical treatment in steps 1 or 2 | |
No selective arterial embolization in steps 1or 2 | |
Surgical treatment, selective arterial embolization and/or intrauterine tamponade in step 3 | |
Communication, monitoring and investigation: | |
Alert other members of the team in steps 1 or 2 | |
Venipuncture with blood count, hemostasis in steps 1 or 2 | |
Resuscitation measure in steps 1 or 2 |